Anne E. Lykkesfeldt

FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance

Johan Hartman, J. Hartman, E. Lam, 2010, Oncogene.

Breast cancer cells can switch between estrogen receptor α and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance

Kristina B. Emdal, T. Kirkegaard, A. Lykkesfeldt, 2010, Breast Cancer Research and Treatment.

Protein Kinase C α is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells

J. Stenvang, A. Lykkesfeldt, L. B. Frankel, 2007, Breast Cancer Research and Treatment.

Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling

Mads Thomassen, Torben A. Kruse, Qihua Tan, 2013, PloS one.